Hide Board Information

Show Board Information

ERShares Private-Public Crossover ETF XOVR

Board Mod: Add me as mod

Asst Mods:

Last Post: 03/20/2015 2:48:26 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

ERShares Private-Public Crossover ETF (NASDAQ: XOVR) Stock Message Board

1. XOVR Company Profile

    

2. XOVR Time & Sales

    

3. XOVR Recent News

    

4. XOVR Filings

    

5. XOVR Financials

    

6. XOVR Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	ENTR 3.00 Entropic Communications $ENTR stock	clayton	03/20/2015 2:48:26 PM
9	ENTR 2.98 Entropic Communications $ENTR stock	clayton	03/19/2015 10:08:59 AM
8	ENTR 3.00 Entropic Communications Stock Charts	chartguy89	03/06/2015 1:25:48 AM
7	ENTR Stock is number 159 for the largest	danrocks	02/10/2015 1:26:46 PM
6	ENTR 2.67 Entropic Communications Stock Charts	chartguy89	11/12/2014 3:22:57 AM
5	ENTR 2.73 Entropic Communications $ENTR added to	clayton	11/11/2014 11:57:55 AM
4	ENTR 2.71 Entropic Communications Stock Charts	chartguy89	11/11/2014 3:34:37 AM
3	ENTR Year to date has changed -42.34% percent.	Jake13	11/11/2014 2:17:54 AM
2	Latest Entropic Communications (ENTR) Headlines	Stock_Tracker	03/12/2014 8:43:08 PM
1	ENTR Stock Charts Last: +0.01 Thursday, February	chartguy89	02/27/2014 1:26:15 AM

Recent Articles

• Opportunity for Wolfspeed Investors to Pursue Class Action
• Kyverna Therapeutics Investors Alert Over Recent Class Action
• Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
• Urgent Alert for Symbotic Investors Regarding Class Action
• Investors Reminded of Key Deadline in PACS Group Lawsuits
• Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
• Important Update for Rentokil Investors on Class Action Lawsuit
• Important Update for Match Group Investors: Legal Actions Ahead
• Investors Urged to Act in Zeta Global Class Action Case
• Celsius Holdings Investors: Important Litigation Updates
• ASML Holding Class Action: Important Update for Investors
• Deadline Approaches for Hasbro Shareholders in Class Action
• Critical Update for Toronto-Dominion Bank Investors in Class Action
• Investors of Kyverna Therapeutics Can Pursue Class Action
• Xi Jinping Supports Hong Kong's Economic Strategies and Development
• Solar Alliance Energy Gains Shareholder Approval in Key Meeting
• Fruit Street Health Enhances Diabetes Prevention with Meals
• CNOOC Limited Partners with INEOS Energy in New Agreement
• Exciting Collaboration: Celebrate Japan's Fruit Culture
• Investors Urged to Act Before Deadline in Xiao-I Class Action
• Karma Sauce Applauds First We Feast's Bold New Direction
• Cassava Sciences Investors Encouraged to Act on Stock Losses
• Investors Warned of Upcoming Deadline in WM Technology Case
• Investors Urged to Act: Acadia Healthcare Class Action Deadline
• Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
• Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
• Legal Action Announced for Five9, Inc. Investors Following Stock Decline
• Legal Action Launched for Kyverna Therapeutics Investors
• Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
• Haloid Enhances Safety in Film Productions with Reviews
• Insights on the Growing Demand for Edible Coatings in Produce
• Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
• Legal Update: Toronto-Dominion Bank Securities Class Action
• Key Updates from Nasdaq on the Nasdaq-100 Index Changes
• TeraBox Revolutionizes File Sharing with Free Unlimited Service
• Kessler Topaz Takes Action Against Enphase Energy for Fraud
• Demesne Resources Completes Second Tranche of Financing
• Spiro Celebrated as One of the Top Agencies in Marketing
• Global Uranium Corp. Launches Strategic Marketing Efforts
• UnitedHealth Group Clarifies Misconceptions and Updates Claims
• Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
• Acadia Healthcare Investors Urged to Take Action on Lawsuit
• Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
• Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
• Hola Prime's Innovative Vision: New Marketing Director Appointed
• Teamsters Advocate for Stronger Standards on Autonomous Vehicles
• BioVaxys Secures Funding and Enters Debt Settlement Agreement
• Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
• OFS Credit Company Shares November Net Asset Value Insights
• New FDA Approval for Crenessity Enhances CAH Treatment Options